Literature DB >> 207947

Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis).

M Berger, H Zimmermann-Telschow, P Berchtold, H Drost, W A Müller, F A Gries, H Zimmermann.   

Abstract

Blood amino acid concentrations were determined in the postabsorptive state in nine patients with insulin excess (functioning insulinomas), nine juvenile-type diabetics with insulin deficiency (diabetic ketosis due to insulin withdrawal), six juvenile diabetics in moderate metabolic control, and five healthy control subjects. Blood branched-chain amino acid (BCAA) levels were elevated in diabetic ketosis and decreased in patients with insulinomas. Blood concentrations of BCAA were significantly correlated to blood glucose levels, and in diabetics they were also correlated to blood ketone bodies, serum free fatty acids, and glycerol levels. These data indicate an inverse relationship between circulating effective insulin levels and blood BCAA concentrations. It is suggested that blood levels of BCAA might represent an indicator of insulin-dependent alterations of protein metabolism.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207947     DOI: 10.1016/0026-0495(78)90214-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.

Authors:  G Marchesini; M Zoli; C Dondi; A Angiolini; A Melli; E Pisi
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

2.  Effect of branched chain amino acid infusions on body protein metabolism in cirrhosis of liver.

Authors:  P D Wright; J D Holdsworth; P Dionigi; M B Clague; O F James
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

3.  Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes.

Authors:  Ian R Lanza; Shucha Zhang; Lawrence E Ward; Helen Karakelides; Daniel Raftery; K Sreekumaran Nair
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

4.  Polyamine and amino acid content, and activity of polyamine-synthesizing decarboxylases, in liver of streptozotocin-induced diabetic and insulin-treated diabetic rats.

Authors:  M E Brosnan; B V Roebothan; D E Hall
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

5.  Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.

Authors:  B Limberg; B Kommerell
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

6.  Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.

Authors:  W A Muller; M Berger; P Suter; H J Cüppers; J Reiter; T Wyss; P Berchtold; F H Schmidt; J P Assal; A E Renold
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Maple syrup urine disease--therapeutic use of insulin in catabolic states.

Authors:  U Wendel; U Langenbeck; I Lombeck; H J Bremer
Journal:  Eur J Pediatr       Date:  1982-11       Impact factor: 3.183

8.  Brain transmitter precursors and metabolites in diabetic ketoacidosis.

Authors:  G Curzon; B D Kantamaneni; N Callaghan; P A Sullivan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-06       Impact factor: 10.154

9.  Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.

Authors:  P Vannini; G Marchesini; G Forlani; A Angiolini; A Ciavarella; M Zoli; E Pisi
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

10.  Glucagon deficiency associated with hypoglycaemia and the absence of islet cell antibodies in the polyglandular failure syndrome before the onset of insulin-dependent diabetes mellitus: a case report.

Authors:  A A Starke; I Valverde; G F Bottazzo; M Tsotsalas; H Zimmermann
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.